Aptamer Group Plc (P0J) AI Stock Analysis

Top Page

Aptamer Group Plc

(Frankfurt:P0J)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Revenue reboundThe return to revenue growth after weakness through 2024 indicates some stabilization in customer demand and commercial activity. If maintained, a larger revenue base could improve operating leverage, support investment in aptamer development, and help the company progress toward sustainable scale.

Negative Factors

Persistent deep lossesProfitability remains the central fundamental weakness because operating costs are still far above the revenue base. Continued deep losses limit internally generated funding, weaken returns on capital, and make progress toward a self-sustaining business dependent on substantial improvement in scale or cost control.

Aptamer Group Plc (P0J) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 10.23M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -9.8
Beta (1Y): -3.37
Revenue Growth: 24.08%
EPS Growth: 56.25%
Country: Germany
Employees: 34
Sector: Healthcare
Sector Strength: 51
Industry: Biotechnology

Aptamer Group Plc Business Overview & Revenue Model

Company Description

Aptamer Group plc, an international company headquartered in York, United Kingdom, specializes in providing advanced binders for applications spanning research, diagnostics, and therapeutics. Their innovative binder technology is engineered to resolv...

Aptamer Group Plc Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:P0J against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
GB:BVXP	89Outperform	GBP 104.50M	13.79	67.81%	7.50%	-1.10%	0.32%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
GB:FAB	49Neutral	GBP 7.51M	-6.06	-97.87%	―	7.38%	44.13%
GB:AVCT	43Neutral	GBP 294.51M	-6.63	-1293.07%	―	―	―
GB:AREC	41Neutral	GBP 37.37M	165.00	3.75%	―	―	―
GB:OBD	40Underperform	GBP 14.45M	-0.27	-451.74%	―	33.37%	86.41%

* Healthcare Sector Average

Performance Comparison

DE:P0J and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:P0J	Aptamer Group Plc	0.02	0.01	100.00%
GB:AVCT	Avacta Group plc	60.50	-11.50	-15.97%
GB:BVXP	Bioventix plc	2000.00	-17.66	-0.88%
GB:OBD	Oxford BioDynamics	0.11	-0.21	-66.56%
GB:FAB	Fusion Antibodies Plc	6.00	-7.50	-55.56%
GB:AREC	Arecor Therapeutics PLC	82.50	11.00	15.38%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Aptamer Group Plc AI Stock Analysis

Top Page